Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Northstar Gold Signs MOU with Hunan Nonferrous Ltd. to Develop Gold Resource (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Eyegate Pharmaceuticals Inc. EYEGV

Healthcare Biotechnology


GREY:EYEGV - Post by User

Eyegate Pharmaceuticals Inc.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(169)
•••
Post by whytestockson Feb 01, 2024 12:15pm
47 Views
Post# 35857312

What's Going On With Kiora Pharmaceuticals Stock? | Benzinga

What's Going On With Kiora Pharmaceuticals Stock? | Benzinga
Just In: $KPRX What's Going On With Kiora Pharmaceuticals Stock? | BenzingaKiora Pharmaceuticals, Inc. (NASDAQ:KPRX) shares are trading higher Thursday after the company announced a private placement of up to $45 million a...KPRX - What's Going On With Kiora Pharmaceuticals Stock? | Benzinga

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities